BioVie (BIVI) Institutional Ownership $2.91 -1.00 (-25.58%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$2.62 -0.29 (-9.97%) As of 08/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioVie (NASDAQ:BIVI)CurrentInstitutional OwnershipPercentage4.59%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$9.66MNumber ofInstitutional Sellers(last 12 months)0 Get BIVI Insider Trade Alerts Want to know when executives and insiders are buying or selling BioVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIVI Institutional Buying and Selling by Quarter BioVie Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025NewEdge Advisors LLC54,100$53K0.0%+283.7%0.293% 2/17/2025Squarepoint Ops LLC14,213$28K0.0%N/A0.080% 2/17/2025Two Sigma Investments LP28,713$57K0.0%N/A0.162% 2/17/2025Millennium Management LLC122,619$245K0.0%N/A0.690% 2/14/2025Northern Trust Corp16,878$34K0.0%N/A0.095% 2/13/2025NewEdge Advisors LLC14,100$28K0.0%+14,000.0%0.079% 2/13/2025 Bank of Montreal Can50,000$100K0.0%N/A0.281% 2/12/2025Geode Capital Management LLC123,408$247K0.0%+223.3%0.694% 2/7/2025 Prosperity Wealth Management Inc.31,650$63K0.0%N/A0.178% 1/22/2025 Drive Wealth Management LLC60,000$120K0.0%N/A0.338% Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025 Sanders Morris Harris LLC40,000$85K0.0%N/A0.225% 5/14/2024Sheaff Brock Investment Advisors LLC51,400$27K0.0%+276.9%0.129% 5/7/2024CVI Holdings LLC599,897$317K0.3%N/A1.503% 11/7/2023Jump Financial LLC10,000$34K0.0%N/A0.027% 10/30/2023Summit Trail Advisors LLC10,100$34K0.0%N/A0.027% 10/25/2023Crescent Grove Advisors LLC11,000$38K0.0%N/A0.030% 10/24/2023 Bank of New York Mellon Corp15,955$54K0.0%-51.2%0.043% 8/29/2023 Garde Capital Inc.24,163$104K0.0%+40.8%0.066% 7/20/2023AJ Wealth Strategies LLC23,474$101K0.0%+52.2%0.065% 7/11/2023 FNY Investment Advisers LLC8,986$38K0.0%N/A0.025% 5/4/2023Barclays PLC54,117$437K0.0%+117.7%0.150% 4/28/2023AJ Wealth Strategies LLC15,428$125K0.0%N/A0.043% 2/24/2023 Garde Capital Inc.17,163$133K0.0%N/A0.049% 2/14/2023683 Capital Management LLC16,110$125K0.0%N/A0.053% 2/14/2023swisspartners Ltd.294,346$2.29M2.9%+82.8%0.964% 2/7/2023Commonwealth Equity Services LLC12,175$94K0.0%N/A0.040% 2/1/2023 Bank of Montreal Can10,000$78K0.0%N/A0.033% 1/30/2023 International Assets Investment Management LLC10,500$82K0.0%N/A0.034% 1/10/2023 FNY Investment Advisers LLC14,200$110K0.2%N/A0.047% 11/15/2022Pura Vida Investments LLC36,617$91K0.0%N/A0.120% 5/4/2022swisspartners Ltd.10,367$1.87M1.3%-87.1%0.042% 2/14/2022Long Focus Capital Management LLC20,000$90K0.0%N/A0.080% 11/16/2021swisspartners Ltd.80,521$542K0.4%+45.0%0.323% 11/12/2021Renaissance Technologies LLC53,100$355K0.0%+90.3%0.214% 8/13/2021Renaissance Technologies LLC27,900$473K0.0%N/A0.200% 8/13/2021Geode Capital Management LLC22,898$388K0.0%+8.0%0.164% 8/13/2021Vanguard Group Inc.97,804$1.66M0.0%+267.6%0.700% 8/11/2021swisspartners Ltd.55,521$941K0.7%+2.2%0.397% 5/18/2021Millennium Management LLC23,107$447K0.0%-3.7%0.166% 5/17/2021Ameriprise Financial Inc.90,876$1.76M0.0%N/A0.651% He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now(Data available from 1/1/2016 forward) BIVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIVI shares? During the previous two years, 17 institutional investors and hedge funds held shares of BioVie. The most heavily invested institutionals were CVI Holdings LLC ($317K), Geode Capital Management LLC ($247K), Millennium Management LLC ($245K), Drive Wealth Management LLC ($120K), Garde Capital Inc. ($104K), Bank of Montreal Can ($100K), and Sanders Morris Harris LLC ($85K).Learn more on BioVie's institutional investors. What percentage of BioVie's stock is owned by institutional investors? 4.59% of BioVie's stock is owned by institutional investors. Learn more on BIVI's institutional investor holdings. Which institutional investors have been buying BioVie's stock? Of the 16 institutional investors that purchased BioVie's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: CVI Holdings LLC ($599.90K), Millennium Management LLC ($122.62K), Geode Capital Management LLC ($85.23K), Drive Wealth Management LLC ($60K), NewEdge Advisors LLC ($54K), Bank of Montreal Can ($50K), and Sanders Morris Harris LLC ($40K). How much institutional buying is happening at BioVie? Institutional investors have bought a total of 503,307 shares in the last 24 months. This purchase volume represents approximately $9.66M in transactions. Related Companies NRx Pharmaceuticals Institutional Ownership Renovaro Institutional Ownership Alterity Therapeutics Institutional Ownership RenovoRx Institutional Ownership Senti Biosciences Institutional Ownership Exicure Institutional Ownership Gain Therapeutics Institutional Ownership Jasper Therapeutics Institutional Ownership PepGen Institutional Ownership Eliem Therapeutics Institutional Ownership This page (NASDAQ:BIVI) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
